The winners and losers of Biden’s plans to expand coverage of weight-loss drugs US President Joe Biden wants to expand the ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

A new study published in the journal Jama estimated that more than 137 million American adults are eligible for medications ...

Ozempic, a weight loss medication, can lead to both positive and negative mood changes. Learn how it affects personality and ...

Campus Chemical Instrument Center, Mass Spectrometry & Proteomics Facility, The Ohio State University, Columbus, USA ...

Ah, Thanksgiving: a time to gather ’round with friends and family, reflect on what we’re grateful for, and, of course, eat.

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

GLP-1 drugs such as Ozempic and Mounjaro have been heralded as some of the most important drug breakthroughs ever . This has led to huge demand for ...

Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.

Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.